Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape - Biogen (NASDAQ:BIIB)

Geron Corporation (GERN) was a big mover last session with its shares surging over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost over 1% since Nov 3.

This clinical stage biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Geron currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the biomedical industry may consider stocks like Affymetrix Inc. (AFFX), Biogen Idec Inc. (BIIB) and Illumina Inc. (ILMN). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

GERON CORP (GERN): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs